These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 16774291)

  • 1. The relationship between ex ante mortality risk and end-of-life medical costs.
    Howard DH; Culler SD; Druss BG; Thorpe KE
    Appl Health Econ Health Policy; 2006; 5(1):37-44. PubMed ID: 16774291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in inpatient treatment intensity among Medicare beneficiaries at the end of life.
    Barnato AE; McClellan MB; Kagay CR; Garber AM
    Health Serv Res; 2004 Apr; 39(2):363-75. PubMed ID: 15032959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hospice Use, Hospitalization, and Medicare Spending at the End of Life.
    Zuckerman RB; Stearns SC; Sheingold SH
    J Gerontol B Psychol Sci Soc Sci; 2016 May; 71(3):569-80. PubMed ID: 26655645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Site of Death, Place of Care, and Health Care Transitions Among US Medicare Beneficiaries, 2000-2015.
    Teno JM; Gozalo P; Trivedi AN; Bunker J; Lima J; Ogarek J; Mor V
    JAMA; 2018 Jul; 320(3):264-271. PubMed ID: 29946682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medicare beneficiaries' costs of care in the last year of life.
    Hogan C; Lunney J; Gabel J; Lynn J
    Health Aff (Millwood); 2001; 20(4):188-95. PubMed ID: 11463076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of preventable acute care spending to total spending for high-cost Medicare patients.
    Joynt KE; Gawande AA; Orav EJ; Jha AK
    JAMA; 2013 Jun; 309(24):2572-8. PubMed ID: 23797716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physicians' political preferences and the delivery of end of life care in the United States: retrospective observational study.
    Jena AB; Olenski AR; Khullar D; Bonica A; Rosenthal H
    BMJ; 2018 Apr; 361():k1161. PubMed ID: 29643089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are regional variations in end-of-life care intensity explained by patient preferences?: A Study of the US Medicare Population.
    Barnato AE; Herndon MB; Anthony DL; Gallagher PM; Skinner JS; Bynum JP; Fisher ES
    Med Care; 2007 May; 45(5):386-93. PubMed ID: 17446824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medicare Cost at End of Life.
    Duncan I; Ahmed T; Dove H; Maxwell TL
    Am J Hosp Palliat Care; 2019 Aug; 36(8):705-710. PubMed ID: 30884954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effects of Training Institution Practice Costs, Quality, and Other Characteristics on Future Practice.
    Phillips RL; Petterson SM; Bazemore AW; Wingrove P; Puffer JC
    Ann Fam Med; 2017 Mar; 15(2):140-148. PubMed ID: 28289113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Area-level variations in cancer care and outcomes.
    Keating NL; Landrum MB; Lamont EB; Bozeman SR; McNeil BJ
    Med Care; 2012 May; 50(5):366-73. PubMed ID: 22437623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The intensity and variation of surgical care at the end of life: a retrospective cohort study.
    Kwok AC; Semel ME; Lipsitz SR; Bader AM; Barnato AE; Gawande AA; Jha AK
    Lancet; 2011 Oct; 378(9800):1408-13. PubMed ID: 21982520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rural-Urban Differences in Costs of End-of-Life Care for the Last 6 Months of Life Among Patients with Breast, Lung, or Colorectal Cancer.
    Crouch E; Eberth JM; Probst JC; Bennett K; Adams SA
    J Rural Health; 2019 Mar; 35(2):199-207. PubMed ID: 29656565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medicare HMO impact on utilization at the end of life.
    Fonkych K; O'Leary JF; Melnick GA; Keeler EB
    Am J Manag Care; 2008 Aug; 14(8):505-12. PubMed ID: 18690766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spending patterns in region of residency training and subsequent expenditures for care provided by practicing physicians for Medicare beneficiaries.
    Chen C; Petterson S; Phillips R; Bazemore A; Mullan F
    JAMA; 2014 Dec; 312(22):2385-93. PubMed ID: 25490329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prescription drug spending for Medicare+Choice beneficiaries in the last year of life.
    Fahlman C; Lynn J; Doberman D; Gabel J; Finch M
    J Palliat Med; 2006 Aug; 9(4):884-93. PubMed ID: 16910803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Demographic and social characteristics and spending at the end of life.
    Shugarman LR; Decker SL; Bercovitz A
    J Pain Symptom Manage; 2009 Jul; 38(1):15-26. PubMed ID: 19615623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in Medicare payments in the last year of life.
    Lubitz JD; Riley GF
    N Engl J Med; 1993 Apr; 328(15):1092-6. PubMed ID: 8455667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age and gender differences in Medicare expenditures at the end of life for colorectal cancer decedents.
    Shugarman LR; Bird CE; Schuster CR; Lynn J
    J Womens Health (Larchmt); 2007 Mar; 16(2):214-27. PubMed ID: 17388738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of Peer Physicians on Intensity of End-of-Life Care for Cancer Decedents.
    Keating NL; O'Malley AJ; Onnela JP; Gray SW; Landon BE
    Med Care; 2019 Jun; 57(6):468-474. PubMed ID: 31008900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.